InvestorsHub Logo
Followers 122
Posts 17458
Boards Moderated 0
Alias Born 01/06/2014

Re: MedResCollab post# 197703

Thursday, 06/20/2019 11:19:56 AM

Thursday, June 20, 2019 11:19:56 AM

Post# of 426231
MRC - But if elephants take Vascepa, the 31% RRR and CVD MOA from FOURRIER is due to patent infringement... The same hypothesis can be said of Dr. BHATT HsCRP and TG lowering, in the higher spectrum of the debacle of AdCom.

That said, the LDL levels in JELIS is due to residual risk from 25-40% statin use, as in coordination from the lower functioning lateral jigsaw embankment.

Sorry for headaches to those reading, just trying to match the logic of the post that I'm replying to!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News